Indications and uses
▪ for the temporary relief of burning & irritation due to dryness of the eye ▪ for use as a protectant against further irritation or to relieve dryness of the eye ▪ relieves redness of the eye due to minor eye irritations
▪ for the temporary relief of burning & irritation due to dryness of the eye ▪ for use as a protectant against further irritation or to relieve dryness of the eye ▪ relieves redness of the eye due to minor eye irritations
Instill 1 to 2 drops in the affected eye(s) up to four times daily.
Drug Facts
Polyvinyl alcohol 0.5%
Povidone 0.6%
Lubricant
Tetrahydrozoline hydrochloride 0.05%
Redness reliever
For external use only
solution changes color or becomes cloudy.
narrow angle glaucoma.
If swallowed, get medical help or contact a Poison Control Center(1-800-222-1222) right away.
Instill 1 to 2 drops in the affected eye(s) up to four times daily.
Benzalkonium Chloride, Disodium Hydrogen Phosphate Anhydrous, Disodium Edetate, Mannitol , Potassium Chloride, Purified Water, Sodium dihydrogen Phosphate Dihydrate, Sodium Chloride, Sodium Citrate , May Contain Hydrochloric Acid and/or Sodium Hydroxide to Adjust PH.
TAMPER EVIDENT
Do not use if tape seals on carton top and bottom flaps are damaged or missing
To open cap, PUSH DOWN AND TURN.
*This product is not manufactured or distributed by Medtech Products, Inc., owner of the registered trademark Clear Eyes® Triple Action.
DISTRIBUTED BY CARDINAL HEALTH
DUBLIN, OHIO 43017
www.myleader.com 1-800-200-6313
Made in India
100% Money Back Guarantee
Return to place of purchase if not satisfied.
Code: MH/DRUGS/28-KD/283
CIN 5698352 | REV. 2/21 |
LEADER™
NDC 70000-0087-1
Sterile / Triple Action
Eye
Irritation
Relief
Polyvinyl Alcohol / Povidone
Tetrahydrozoline Hydrochloride
Lubricant / Redness Reliever
Actual Bottle Size on Side Panel
COMPARE TO CLEAR EYES® TRIPLE ACTION active ingredients*
100% Money Back Guarantee
0.5 FL OZ (15 mL)

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1235569 | polyvinyl alcohol 0.5 % / povidone 0.6 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution | PSN | 3 |
| 1235569 | polyvinyl alcohol 0.005 ML/ML / povidone 6 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution | SCD | 3 |
| 1235569 | polyvinyl alcohol 0.5 % / povidone 0.6 % / tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution | SY | 3 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70000-0087-1 | 2025-09-22 | C162847 | 48780-1 | 1030e365-0839-111a-e063-dadaa90a10e2 | Sterile Eyes Irritation Relief Triple Action |
| 70000-0087-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-0839-111a-e063-dadaa90a10e2 | Sterile Eyes Irritation Relief Triple Action |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0087-1 | Eyes Irritation Relief | 15 mL in 1 BOTTLE, DROPPER | LIQUID | 15 | 3 | |
| 70000-0087-1 | Eyes Irritation Relief | 1 in 1 BOX | LIQUID | 1 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0087-1 | ML - Milliliter | 70000-0087 | 88613991-c51f-4c55-b1c2-8a4577e5a90a | 1 | 2022-04-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70000-0087 | 70000-0087-1 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | 70000-0087-1 70000-0087 70000008701 aaaabf8c-8ca5-4fe3-8e21-ba270c7f3991 bd2608c6-ffdf-352a-e053-2995a90a26a8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.